Infusion Express Finances Next Phase of Growth
Intravenous drug therapy provider Infusion Express (IVX) has raised $13.5 million of growth capital in a round led by McKesson Ventures and Health Velocity Capital, with additional support from Nueterra Capital. Infusion Express will use the money to expand its services to chronically ill patients,...